Equities

Purple Biotech Ltd

Purple Biotech Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.615
  • Today's Change0.010 / 1.64%
  • Shares traded64.35k
  • 1 Year change-63.82%
  • Beta1.0946
Data delayed at least 15 minutes, as of Jun 06 2024 20:50 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

  • Revenue in USD (TTM)0.00
  • Net income in USD-18.76m
  • Incorporated1968
  • Employees20.00
  • Location
    Purple Biotech Ltd4 Oppenheimer St., Science ParkREHOVOT 7670104IsraelISR
  • Phone+972 39333121
  • Fax+972 35097196
  • Websitehttps://purple-biotech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neurobo Pharmaceuticals Inc0.00-16.58m18.69m8.00--1.86-----3.26-3.260.002.050.00----0.00-68.36-95.57-108.01-135.64------------0.00------10.72--75.54--
Correlate Energy Corp7.95m-13.85m18.86m19.00------2.37-0.3747-0.37470.2157-0.1452.76--26.10418,160.50-481.76-315.47----17.9815.42-174.38-201.03---1.07----122.2046.12-78.54------
KALA BIO Inc0.00-39.55m18.93m43.00--2.84-----15.15-15.150.002.370.00----0.00-63.15-57.83-76.71-69.32--57.06---1,553.61---12.260.8382---100.00--5.85---17.31--
MEI Pharma Inc66.75m26.16m19.06m46.000.72860.37340.71880.28553.933.9310.027.660.6498--29.151,451,174.0025.46-25.3130.38-28.59----39.18-122.05----0.00--19.9597.5641.53------
Evaxion Biotech A/S - ADR124.00k-14.69m19.14m49.00------154.35-56.83-56.830.0902--------2,530.61---100.11---131.65-----11,846.77-131,560.30------------4.51--65.53--
Neurosense Therapeutics Ltd0.00-11.28m19.48m16.00---------0.7625-0.76250.00-0.12190.00----0.00-207.24---395.72----------------------8.59------
Lyra Therapeutics Inc1.68m-68.88m20.00m109.00--0.258--11.90-1.23-1.230.02971.270.0143----19,090.91-58.52-58.01-68.02-68.69-----4,099.82-6,235.31----0.00--14.314.60-13.39--95.14--
Indaptus Therapeutics Inc0.00-14.98m20.24m7.00--2.16-----1.78-1.780.001.100.00----0.00-87.86-66.55-97.46-81.23------------0.00-------7.68------
Bioxytran Inc0.00-4.30m20.47m2.00---------0.0297-0.02970.00-0.00170.00-------2,431.80-1,420.53---------------7.69---------73.71------
Ibio Inc50.00k-17.13m20.52m26.00--0.8153--410.49-13.10-17.090.02622.920.0011--0.00651,923.08-36.24-28.09-67.39-32.63-----34,258.00-1,467.30----0.3666---100.00--0.9764--42.90--
Purple Biotech Ltd - ADR0.00-18.76m20.55m20.00--0.7151-----0.7402-0.74020.001.130.00----0.00-40.57---47.99--------------0.0098------8.25------
Jaguar Health Inc10.14m-38.32m20.63m49.00--1.60--2.03-78.63-78.639.903.180.18060.23978.12206,938.80-69.22-95.29-122.86-163.5479.0767.28-383.35-522.281.39-2.780.6919---18.3617.1912.97------
Cumberland Pharmaceuticals, Inc.38.83m-8.42m21.00m91.00--0.7624--0.541-0.596-0.5962.721.940.45420.88123.08426,654.70-9.83-7.03-14.07-9.5283.5479.95-21.65-17.641.21-37.100.3717---5.856.15-12.73---36.17--
Polypid Ltd0.00-24.25m21.59m59.00--3.02-----12.35-12.350.001.490.00----0.00-84.94-76.92-120.03-89.61-----------28.720.5498------39.67---42.34--
Forte Biosciences Inc0.00-32.14m21.64m11.00--0.7534-----1.03-1.030.000.78820.00----0.00-93.54-72.06-104.30-82.27-------491,850.00----0.00-------126.79---46.29--
Sol Gel Technologies Ltd1.72m-22.86m22.29m36.00--0.6826--12.96-0.8222-0.82220.06191.170.0387--0.515447,777.78-51.40-31.60-57.29-35.49-----1,329.13-135.76----0.00---59.9864.50-82.52---33.78--
Data as of Jun 06 2024. Currency figures normalised to Purple Biotech Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.